Studies related to Erythema and Feverfew

Anti-inflammatory Activity Of Parthenolide-depleted Feverfew (Tanacetum Parthenium)

Effect Decrease
Trial Design Double blind
Trial Length 24 hours
Number of Subjects 8
Gender Both Genders
Age Range 18-29, 30-44, 45-64
Notes for this study:
A feverfew product without parthenolide was still able to inhibit irritant-induced reddening of the skin that normally occurs via pro-inflammatory prostaglandin release, up to 68.3% inhibition at 1% topical feverfew without parthenolide and was more potent than the positive control of ibuprofen